SARS CoV 2 News and Research

RSS

Review: One in five COVID-19 patients may only show gastrointestinal symptoms

Almost one in five patients with COVID-19 may only show gastrointestinal symptoms, according to a review of academic studies published in the journal Abdominal Radiology. The findings of the review suggest abdominal radiologists need to remain vigilant during the pandemic while imaging patients.

3 Nov 2020

Beta-blockers could be used to treat COVID-19, study finds

Beta-blockers could potentially be used to treat COVID-19, according to a new international study by Italian and Australian scientists.

3 Nov 2020

Scientists identify neutralizing human monoclonal antibodies against SARS-CoV-2

University of Pittsburgh School of Medicine scientists have discovered the fastest way to identify potent, neutralizing human monoclonal antibodies against SARS-CoV-2, the virus that causes COVID-19.

3 Nov 2020

Large differences in reported COVID-19 death rates can be misleading

Simply comparing the total number of deaths across countries may provide a misleading representation of the underlying level of transmission of SARS-CoV-2, the virus that causes COVID-19, because of large differences in reported COVID-19 death rates in elderly populations in different countries.

3 Nov 2020

Limiting gatherings could significantly reduce the number of infections

There have been many documented cases of Covid-19 "super-spreading" events, in which one person infected with the SARS-CoV-2 virus infects many other people.

3 Nov 2020

Remdesivir metabolite GS-441524 inhibits SARS CoV-2 in mouse model, finds study

This new study titled, "Remdesivir Metabolite GS-441524 Efficiently Inhibits SARS-CoV-2 Infection in Mouse Model," was released online as a preprint on the bioRxiv* server, prior to undergoing the peer-review process.

2 Nov 2020

Estonian researchers provide clues to control the aggressive nature of SARS-CoV-2

Recent study by Estonian researchers in University of Tartu explains how coronavirus is activated before attacking the cell and what could help to impede that.

2 Nov 2020

Only 56 percent of people intend to have free flu vaccination in the U.K. amid COVID

Now, a team of researchers at Keele University and Public Health England aimed to determine how many residents in the U.K. intend to get flu shots amid the COVID-19 pandemic. The researchers found that 55.8 percent of people intended to have the vaccination.

2 Nov 2020

Children with asthma having fewer attacks amid the coronavirus pandemic, study says

During the coronavirus disease (COVID-19) pandemic, an international team of researchers has found that children with asthma experienced fewer upper respiratory tract infections, emergency visits, fever episodes, asthma attacks, and hospital admissions compared with the previous year.

2 Nov 2020

Global collaboration provides a COVID-19 disease map

A collaboration of researchers from 120 different institutes across 30 countries including France, Germany, Australia, Japan, USA, India, Turkey, Brazil, and Canada initiated an effort to develop a COVID-19 Disease Map - a collection of computational models and diagrams of molecular mechanisms implicated in COVID-19.

2 Nov 2020

SARS-CoV-2 spike D614G variant exhibits enhanced replication and transmissibility

A team of scientists from Switzerland, Germany, and the USA has demonstrated that the S-614G variant can easily bind to the human angiotensin-converting enzyme 2 (ACE2), the cellular gateway of SARS-CoV-2. The variant also showed enhanced replication and transmissibility in animal models.

2 Nov 2020

Research finds detectable but low-level SARS-CoV-2 contamination on public surfaces

A team of researchers at Tufts University found that 8.3 percent of surface samples tested positive for SARS-CoV-2, including crosswalk buttons, trash can handles, and door handles of essential business entrances such as grocery stores, banks, gas stations, and liquor stores.

2 Nov 2020

Research finds increase in risky sexual behavior and STIs despite COVID-19 pandemic

New research launched at the 29th EADV Congress, EADV Virtual, has found that despite the COVID-19 (SARS-CoV-2) lockdown restrictions, diagnosis of sexually transmitted infections (STIs), including gonorrhoea, secondary syphilis and mycoplasma genitalium (MG), have increased.

2 Nov 2020

The Sun plays a role in the evolution of viral respiratory epidemics

Why do most viral epidemics spread cyclically in autumn and winter in the globe's temperate regions? According to an interdisciplinary team of researchers of the Italian National Institute for Astrophysics, the University of Milan, the Lombardy regional agency for the environment and the Don Gnocchi Foundation, the answer is intimately related to our Sun: their theoretical model shows that both the prevalence and evolution of epidemics are strongly correlated with the amount of daily solar irradiation that hits a given location on the Earth at a given time of the year.

2 Nov 2020

Porvair Sciences introduces new 2.2ml 96 deep well plate for SARS-CoV-2 nucleic acid purification

Porvair Sciences has introduced a new 2.2ml 96 deep well plate specifically designed to be fully compatible with the Thermo Scientific™ KingFisher™ range of nucleic acid purification systems.

From Porvair Sciences Limited 2 Nov 2020

Is it safe to resume cruise operations? CDC issues safety guidelines

Nearly a year into the coronavirus disease (COVID-19) pandemic, many countries are easing restrictions to rebuild their economies. At the same time, many industries are trying to return to a new normal, one of which being the cruise sector. Prior to the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and COVID-19, the cruise industry represented 2% of the worldwide travel and tourism industry.

2 Nov 2020

Genomic sequence of the White House "superspreader" event

Now, a new study revealed the genetic signature of the SARS-CoV-2 that spread in the White House and most likely infected President Trump. The team applied genomic epidemiology to shed light on the origins of the outbreak

2 Nov 2020

Exposure to environmental immunotoxicants may worsen outcome of SARS-CoV-2 infection

A team of researchers recently carried out a study in Denmark in which they determined the plasma PFAS concentrations in individuals with a confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

2 Nov 2020

Research shows how remdesivir inhibits SARS-CoV-2 replication

In a recent bioRxiv preprint, a research team from Germany, Goran Kokic et al. study the molecular mechanism of remdesivir-induced stalling of RdRp - using synthetic RNA chemistry, biochemistry, and cryo-electron microscopy.

2 Nov 2020

Ethacridine blocks SARS-CoV-2 with a distinct mode of action

Now, researchers from the University of California, San Francisco, and Stanford University, California, USA, reported a safe and potent antiseptic for use in humans named ethacridine, which effectively inhibits SARS-CoV-2 even at very low concentrations of EC50 ~ 0.08 µM. Their work has is published on the preprint server bioRxiv*.

1 Nov 2020

SARS CoV 2 News and Research

Review: One in five COVID-19 patients may only show gastrointestinal symptoms

Beta-blockers could be used to treat COVID-19, study finds

Scientists identify neutralizing human monoclonal antibodies against SARS-CoV-2

Large differences in reported COVID-19 death rates can be misleading

Limiting gatherings could significantly reduce the number of infections

Remdesivir metabolite GS-441524 inhibits SARS CoV-2 in mouse model, finds study

Estonian researchers provide clues to control the aggressive nature of SARS-CoV-2

Only 56 percent of people intend to have free flu vaccination in the U.K. amid COVID

Children with asthma having fewer attacks amid the coronavirus pandemic, study says

Global collaboration provides a COVID-19 disease map

SARS-CoV-2 spike D614G variant exhibits enhanced replication and transmissibility

Research finds detectable but low-level SARS-CoV-2 contamination on public surfaces

Research finds increase in risky sexual behavior and STIs despite COVID-19 pandemic

The Sun plays a role in the evolution of viral respiratory epidemics

Porvair Sciences introduces new 2.2ml 96 deep well plate for SARS-CoV-2 nucleic acid purification

Is it safe to resume cruise operations? CDC issues safety guidelines

Genomic sequence of the White House "superspreader" event

Exposure to environmental immunotoxicants may worsen outcome of SARS-CoV-2 infection

Research shows how remdesivir inhibits SARS-CoV-2 replication

Ethacridine blocks SARS-CoV-2 with a distinct mode of action

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News